8TOP

Cryo-EM structure of HIV-1 Env BG505 DS-SOSIP in complex with antibody GPZ6-b.01 targeting the fusion peptide

8TOP の概要

• エントリーDOI: 10.2210/pdb8top/pdb
• EMDBエントリー: 41310 41459
• 分子名称: HIV-1 BG505 DS-SOSIP gp120, HIV-1 BG505 DS-SOSIP glycoprotein gp41, Heavy chain of antibody GPZ6-b.01, ... (7 entities in total)
• 機能のキーワード: hiv-1 envelope, antibody, gpz6-b.01, shiv, bg505 ds-sosip, neutralization, immunization, viral protein-immune system complex, viral protein/immune system
• 由来する生物種: Human immunodeficiency virus 1; 詳細
• タンパク質・核酸の鎖数: 24
• 化学式量合計: 744589.67

構造登録者

Zhou, T.,Morano, N.C.,Roark, R.S.,Kwong, P.D. (登録日: 2023-08-03, 公開日: 2024-08-07, 最終更新日: 2025-01-15)

主引用文献

Wang, H.,Cheng, C.,Dal Santo, J.L.,Shen, C.H.,Bylund, T.,Henry, A.R.,Howe, C.A.,Hwang, J.,Morano, N.C.,Morris, D.J.,Pletnev, S.,Roark, R.S.,Zhou, T.,Hansen, B.T.,Hoyt, F.H.,Johnston, T.S.,Wang, S.,Zhang, B.,Ambrozak, D.R.,Becker, J.E.,Bender, M.F.,Changela, A.,Chaudhary, R.,Corcoran, M.,Corrigan, A.R.,Foulds, K.E.,Guo, Y.,Lee, M.,Li, Y.,Lin, B.C.,Liu, T.,Louder, M.K.,Mandolesi, M.,Mason, R.D.,McKee, K.,Nair, V.,O'Dell, S.,Olia, A.S.,Ou, L.,Pegu, A.,Raju, N.,Rawi, R.,Roberts-Torres, J.,Sarfo, E.K.,Sastry, M.,Schaub, A.J.,Schmidt, S.D.,Schramm, C.A.,Schwartz, C.L.,Smith, S.C.,Stephens, T.,Stuckey, J.,Teng, I.T.,Todd, J.P.,Tsybovsky, Y.,Van Wazer, D.J.,Wang, S.,Doria-Rose, N.A.,Fischer, E.R.,Georgiev, I.S.,Karlsson Hedestam, G.B.,Sheng, Z.,Woodward, R.A.,Douek, D.C.,Koup, R.A.,Pierson, T.C.,Shapiro, L.,Shaw, G.M.,Mascola, J.R.,Kwong, P.D.
Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaques.
Cell, 187:7214-7231.e23, 2024

PubMed Abstract: An antibody-based HIV-1 vaccine will require the induction of potent cross-reactive HIV-1-neutralizing responses. To demonstrate feasibility toward this goal, we combined vaccination targeting the fusion-peptide site of vulnerability with infection by simian-human immunodeficiency virus (SHIV). In four macaques with vaccine-induced neutralizing responses, SHIV infection boosted plasma neutralization to 45%-77% breadth (geometric mean 50% inhibitory dilution [ID] ∼100) on a 208-strain panel. Molecular dissection of these responses by antibody isolation and cryo-electron microscopy (cryo-EM) structure determination revealed 15 of 16 antibody lineages with cross-clade neutralization to be directed toward the fusion-peptide site of vulnerability. In each macaque, isolated antibodies from memory B cells recapitulated the plasma-neutralizing response, with fusion-peptide-binding antibodies reaching breadths of 40%-60% (50% inhibitory concentration [IC] < 50 μg/mL) and total lineage-concentrations estimates of 50-200 μg/mL. Longitudinal mapping indicated that these responses arose prior to SHIV infection. Collectively, these results provide in vivo molecular examples for one to a few B cell lineages affording potent, broadly neutralizing plasma responses.

PubMed: 39471811
DOI: 10.1016/j.cell.2024.10.003

実験手法

ELECTRON MICROSCOPY (3.52 Å)